Literature DB >> 33463051

Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.

Esther Rey1, Javier Ampuero2,3, Francisca Molina-Jiménez3,4, Patricia Marañón1, Yaiza García-García1, Rocío Múñoz-Hernández2,3, Manuel Romero-Gómez2,3, Carmelo García-Monzón1,3, Pedro Majano3,4, Águeda González-Rodríguez1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33463051      PMCID： PMC7810262          DOI： 10.1002/ctm2.275

Source DB:  PubMed          Journal:  Clin Transl Med        ISSN： 2001-1326


× No keyword cloud information.
  8 in total

Review 1.  Systematic review: chronic viral hepatitis and metabolic derangement.

Authors:  Chia-Chi Wang; Pin-Nan Cheng; Jia-Horng Kao
Journal:  Aliment Pharmacol Ther       Date:  2019-11-20       Impact factor: 8.171

Review 2.  Mechanisms of hepatitis C virus-related insulin resistance.

Authors:  Francesco Negro
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-02-25       Impact factor: 2.947

3.  Exploring lipid and apolipoprotein levels in chronic hepatitis C patients according to their response to antiviral treatment.

Authors:  Gilmar de Souza Lacerda; Thalia Medeiros; Natalia Fonseca do Rosário; Regina Helena Saramago Peralta; Mauro Jorge Cabral-Castro; Eliane Bordalo Cathalá Esberard; Thaís Guaraná de Andrade; Analúcia Rampazzo Xavier; Andrea Alice Silva
Journal:  Clin Biochem       Date:  2018-07-18       Impact factor: 3.281

4.  Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance.

Authors:  Sutapa Banerjee; Kousuke Saito; Malika Ait-Goughoulte; Keith Meyer; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

Review 5.  Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2.

Authors:  K D Copps; M F White
Journal:  Diabetologia       Date:  2012-08-08       Impact factor: 10.122

6.  Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway.

Authors:  Lin Deng; Ikuo Shoji; Wataru Ogawa; Shusaku Kaneda; Tomoyoshi Soga; Da-peng Jiang; Yoshi-Hiro Ide; Hak Hotta
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

Review 7.  Sofosbuvir, a nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus infection.

Authors:  David Alan Herbst; K Rajender Reddy
Journal:  Expert Opin Investig Drugs       Date:  2013-03-01       Impact factor: 6.206

8.  Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis.

Authors:  Fahed Parvaiz; Sobia Manzoor; Jawed Iqbal; Mehuli Sarkar-Dutta; Muhammad Imran; Gulam Waris
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.